Healthcare RayzeBio, Neumora Perk Up the IPO Market, Elevating $561M for Medical Trials By / September 17, 2023
Healthcare Acelyrin Plans IPO to Fund Pivotal Checks of Drug That Might Rival AbbVie’s Humira By / April 15, 2023
